Sabril

Links shared publicly online about this topic

Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures

fda.gov — “Sabril (vigabatrin) oral solution has been approved by the u.s. food and drug administration to treat infantile spasms in children ages 1 month to 2 years. sabril is the first drug in the united states approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months. the disorder can be debilitating because of the frequency of difficult-to-control daily seizures.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on August 21, 2009 at 6:04 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures http://bit.ly/2Hwoh

3 years ago...

Sabril Approved By FDA To Treat Spasms In Infants And Epileptic Seizures

medicalnewstoday.com — “Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United SView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 24, 2009 at 2:47 pm By:

mnt_neurology MNT Neurology News Neurology and Health News

Sabril Approved By FDA To Treat Spasms In Infants And Epileptic Seizures: Sabril (vigabatrin) Oral Solution has .. http://bit.ly/3ySvRQ

3 years ago...

Sabril available for infantile spasms and adult epileptic seizures - MPR

empr.com — “Lundbeck has made available Sabril (vigabatrin) powder for oral solution and tablets for the treatment of infantile spasms and refractory complex partial seizures.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 21, 2009 at 7:36 pm By:

eMPR MPR Medical Publisher

MPR News: Sabril available for infantile spasms and adult epileptic seizures: Lundbeck has made availab.. http://bit.ly/XkmFg

3 years ago...

Sabril approved for infantile spasms and adult epileptic seizures - MPR

empr.com — “The FDA has approved Sabril (vigabatrin, from Lundbeck) oral solution as monotherapy for infantile spasms in children 1 month to 2 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on August 24, 2009 at 3:22 pm By:

eMPR MPR Medical Publisher

MPR News: Sabril approved for infantile spasms and adult epileptic seizures : The FDA has approved Sabr.. http://bit.ly/75nNv

3 years ago...

Lundbeck Inc. Announces FDA Marketing Approval for Sabril for the Treatment of Two Difficult-to-Treat Epilepsies

drugs.com — “Sabril (vigabatrin) is used to treat infantile spasms and complex partial seizures. Includes Sabril side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 23, 2009 at 3:44 am By:

drugscom Drugs.com Health Site

Lundbeck Inc. Announces FDA Marketing Approval for Sabril - http://bit.ly/JYKTQ

3 years ago...

First Post-Baseline Data from the Sabril(R) (vigabatrin) Registry Presented at the American Epilepsy Society Annual Meeting - MarketWatch

marketwatch.com — “First Post-Baseline Data from the Sabril(R) (vigabatrin) Registry Presented at the American Epilepsy Society Annual Meeting - MarketWatchView full resource at marketwatch.com

  • View Related
  • Share

Most Recently Shared on December 5, 2011 at 1:00 pm By:

Wills_Eye Wills Eye Institute Hospital

Wils Eye's Robert Sergott, MD, presented post-baseline vision data on Sabril therapy at AES annual meeting, 12/4/11. http://t.co/I79onXAw

6 months ago...

Weight Loss From Addiction Drug

webmd.com — “Vigabatrin, now being tested as a treatment for cocaine addiction, lessens obese rats' craving for food. They lose about 20% of their body weight.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on August 20, 2008 at 4:30 pm By:

WebMD_News WebMD_News Health News

WebMD Health News Weight Loss From Addiction Drug: Vigabatrin, now being tested as a .. http://tinyurl.com/5mc6w9

4 years ago...

Only Some Epilepsy Drugs Increase Risk of Suicide | Psych Central News

psychcentral.com — “A new study has determined that only some epilepsy drugs increase the risk for suicide. Currently, the Food and Drug Administration (FDA) requires a warning ofView full resource at psychcentral.com

  • View Related
  • Share

Most Recently Shared on July 27, 2010 at 11:33 am By:

psychcentral Psych Central Health Site

News: Only Some Epilepsy Drugs Increase Risk of Suicide http://bit.ly/b3wBIi

2 years ago...

A Long And Deadly Wait - Forbes.com

forbes.com — “Sabril could help babies with brain-destroying seizures. So why did it take so long to approve?View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on September 30, 2009 at 12:37 pm By:

forbeshealth forbeshealth Health News

Why did a drug for kids with seizures take so long to approve? http://bit.ly/13SgXq

3 years ago...

Medical News: FDA Approves First Infantile Spasm Treatment - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA approved the controversial antiseizure solution vigabatrin (Sabril) for spasms in children ages 1 month to 2 years.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 24, 2009 at 10:42 pm By:

MedicalNews Medical News Health News

FDA Approves First Infantile Spasm Treatment http://ow.ly/15MguW

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • eyeonfda

    eyeonfda

    Author of the blog Eye on FDA - www.eyeonfda.com

    View Profile

  • mnt_neurology

    MNT Neurology News

    The latest neurology / neuroscience news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390